HEMATOLOGIC MALIGNANCIES
Clinical trials for HEMATOLOGIC MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC MALIGNANCIES trials appear
Sign up with your email to follow new studies for HEMATOLOGIC MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New transplant method tested for tough blood cancers
Disease control TerminatedThis study tested a modified bone marrow transplant procedure for adults with serious blood cancers like leukemia and lymphoma. It aimed to see if using a partially mismatched donor (like a family member) followed by a specific drug (cyclophosphamide) could control the cancer and…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug combo tested to shield transplant patients from dangerous rejection
Disease control TerminatedThis study tested whether adding the experimental drug itacitinib to standard preventive medications could better protect patients from graft-versus-host disease (GVHD) after a stem cell transplant for blood cancers. It involved 84 participants who were eligible for a reduced-int…
Matched conditions: HEMATOLOGIC MALIGNANCIES
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC